CDP323 Disease area studied Abbreviated title Phase Study ID Registry database Study results Plain language summary Publication (if available) Multiple Sclerosis Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323 Phase 2 C32322 Terminated NCT004845362006-002204-33 LINK Polman, C. et al. Neurology;3-2-2010;74;9 Suppl. 2;A293 62nd Annual Meeting of the American Academy of Neurology (AAN), April 10-17, 2010;Toronto, Canada Multiple Sclerosis CDP323 Biomarker Study Phase 2 C32325 Completed NCT00726648 "Wolf et al. PLoS ONE;2013;8;3;e58438. "
